Blackstone Clarus Gp L.p. - Net Worth and Insider Trading
Blackstone Clarus Gp L.p. Net Worth
The estimated net worth of Blackstone Clarus Gp L.p. is at least $83,949 dollars as of 2024-11-13. Blackstone Clarus Gp L.p. is the 10% Owner of Galera Therapeutics Inc and owns about 1,678,984 shares of Galera Therapeutics Inc (GRTX) stock worth over $83,949. Details can be seen in Blackstone Clarus Gp L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Blackstone Clarus Gp L.p. has not made any transactions after 2019-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Blackstone Clarus Gp L.p.
Blackstone Clarus Gp L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Blackstone Clarus Gp L.p. owns 2 companies in total, including Galera Therapeutics Inc (GRTX) , and Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Blackstone Clarus Gp L.p.’s form 4 insider trades.
Insider Ownership Summary of Blackstone Clarus Gp L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 10 percent owner |
| TALS | Talaris Therapeutics Inc | 2021-05-06 | 10 percent owner |
Blackstone Clarus Gp L.p. Latest Holdings Summary
Blackstone Clarus Gp L.p. currently owns a total of 1 stock. Blackstone Clarus Gp L.p. owns 1,678,984 shares of Galera Therapeutics Inc (GRTX) as of November 12, 2019, with a value of $83,949.
Latest Holdings of Blackstone Clarus Gp L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 1,678,984 | 0.05 | 83,949 |
Holding Weightings of Blackstone Clarus Gp L.p.
Blackstone Clarus Gp L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Blackstone Clarus Gp L.p. has made a total of 0 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years. The most-recent trade in Galera Therapeutics Inc is the acquisition of 250,000 shares on November 12, 2019, which cost Blackstone Clarus Gp L.p. around $3 Million.
Insider Trading History of Blackstone Clarus Gp L.p.
- 1
Blackstone Clarus Gp L.p. Trading Performance
GuruFocus tracks the stock performance after each of Blackstone Clarus Gp L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Blackstone Clarus Gp L.p. is 6.05%. GuruFocus also compares Blackstone Clarus Gp L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Blackstone Clarus Gp L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Blackstone Clarus Gp L.p.'s insider trading performs compared to the benchmark.
Performance of Blackstone Clarus Gp L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -30.04 | | | | | |
| Relative Return to S&P 500(%) | -32.52 | | | | | |
Blackstone Clarus Gp L.p. Ownership Network
Ownership Network List of Blackstone Clarus Gp L.p.
Ownership Network Relation of Blackstone Clarus Gp L.p.
Blackstone Clarus Gp L.p. Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Blackstone Clarus Gp L.p. is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Commercial Officer Mark Bachleda , and Chief Financial Officer Chris Degnan .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Blackstone Clarus Gp L.p. made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , and a net sale of 67,015 shares made by Mel Sorensen .
In summary, during the past 3 months, insiders sold 67,015 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 67,015 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 3,712,809 shares were bought by its insiders, resulting in a net purchase of 3,645,794 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Blackstone Clarus Gp L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Blackstone Clarus Gp L.p.. You might contact Blackstone Clarus Gp L.p. via mailing address: C/o The Blackstone Group Inc., 345 Park Avenue, New York Ny 10154.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
